Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: Mar 27, 2025
Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending
Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025
Read more at globenewswire.com4.61
+0.03 (+0.66%)
Find more stocks in the Stock Screener
ABUS Latest News and Analysis
9 days ago - By: Chartmill
